Novo Nordisk
NVO
₹5,340
Share price
2.14%
Change (1 day)
-50.15%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
EPS for Novo Nordisk (NVO)
EPS in 2023 (TTM): ₹235.77
According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is ₹243.58. In 2022 the company made an earnings per share (EPS) of ₹185.12 an increase over its 2021 EPS that were of ₹169.82.
EPS history for Novo Nordisk from 1996 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | ₹235.77 | 27.36% |
| 2022 | ₹185.12 | 9.01% |
| 2021 | ₹169.82 | 15.08% |
| 2020 | ₹147.57 | 14.83% |
| 2019 | ₹128.51 | -1.68% |
| 2018 | ₹130.70 | 4.96% |
| 2017 | ₹124.53 | 31.08% |
| 2016 | ₹95.00 | -10.33% |
| 2015 | ₹105.94 | 13.91% |
| 2014 | ₹93.01 | 4.03% |
| 2013 | ₹89.40 | -28.81% |
| 2012 | ₹125.58 | 108.9% |
| 2011 | ₹60.11 | 25.59% |
| 2010 | ₹47.87 | 35.01% |
| 2009 | ₹35.45 | -9.17% |
| 2008 | ₹39.03 | 61.35% |
| 2007 | ₹24.19 | 28.96% |
| 2006 | ₹18.76 | 25.63% |
| 2005 | ₹14.93 | 4.17% |
| 2004 | ₹14.33 | 13.55% |
| 2003 | ₹12.62 | 36.87% |
| 2002 | ₹9.22 | -6.99% |
| 2001 | ₹9.92 | 21.56% |
| 2000 | ₹8.16 | 49.45% |
| 1999 | ₹5.46 | 3.78% |
| 1998 | ₹5.26 | 12.15% |
| 1997 | ₹4.69 | 24.74% |
| 1996 | ₹3.76 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | ₹158.65 | -34.87% | 🇺🇸 USA |
 | ₹463.10 | 90.12% | 🇺🇸 USA |
 | ₹338.63 | 39.02% | 🇺🇸 USA |
 | ₹271.26 | 11.36% | 🇫🇷 France |